🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this clinical research study is to learn if temozolomide alone ...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2006-08
Trial ID
NCT00525031
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of recombi...
Status
Unknown
Location
307 Hospital of PLA
Start Date
2015-05
Trial ID
NCT02455596
Treatments Being Tested
The goal of the Phase I part of this clinical research study is to find the...
Status
Terminated
Location
University of Texas MD Anderson Cancer Center
Start Date
2013-02
Trial ID
NCT01409174
Treatments Being Tested
RATIONALE: Medroxyprogesterone may help shrink or slow the growth of kidney...
Status
Completed
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT00416429
Treatments Being Tested
RATIONALE: Vaccines made from a patient's dendritic cells and tumor cells m...
Status
Completed
Location
Norris Cotton Cancer Center at Dartmouth - Hitchcock Medical Center
Start Date
2003-12
Trial ID
NCT00085436
Treatments Being Tested
The rapidly progression of the disease in HIV-HCV co-infected patients just...
Status
Unknown
Location
Hospital General de Alicante
Start Date
2005-11
Trial ID
NCT00611819
Treatments Being Tested
This early phase IIA trial studies how well celecoxib, recombinant interfer...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2018-04-19
Trial ID
NCT03403634
Treatments Being Tested
Comparison of methotrexate versus interferon-alfa 2b on efficacy, safety an...
Status
Terminated
Location
Centrum Onkologii im. prof. F. Łukaszczyka
Start Date
2014-06-01
Trial ID
NCT02323659
Treatments Being Tested
This study is intended to evaluate if 12 or 24 weeks of treatment with GSK3...
Status
Completed
Location
GSK Investigational Site
Start Date
2021-01-28
Trial ID
NCT04676724
Treatments Being Tested
Sixty % of CML patients treated by Imatinib mesylate achieved a major cytog...
Status
Unknown
Location
Franck NICOLINI
Start Date
2004-03
Trial ID
NCT00146913
Treatments Being Tested